FVIII inhibitors in haemophilia A patients who are considered as previously treated patients.

被引：0
|
作者：
von Auer, C [1 ]
Krause, M [1 ]
Miesbach, W [1 ]
Scharrer, I [1 ]
Asmelash, G [1 ]
Stier-Brueck, I [1 ]
机构：
[1] Univ Frankfurt, Dept Internal Med 1, D-6000 Frankfurt, Germany
来源：
BLOOD | 2004年 / 104卷 / 11期
关键词：
D O I：
10.1182/blood.V104.11.4022.4022
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4022
引用
收藏
页码：91B / 92B
页数：2
相关论文
共 50 条
  • [21] Patients' preferences for FVIII reconstitution devices in haemophilia A
    Di Minno, G.
    Halimeh, S.
    Westfeld, M.
    HAEMOPHILIA, 2013, 19 : 68 - 68
  • [22] Tertiary prophylaxis in patients with haemophilia A and FVIII inhibitor
    Smejkal, P.
    Romanova, G.
    Polak, P.
    Penka, M.
    HAEMOPHILIA, 2019, 25 : 157 - 157
  • [23] FVIII inhibitor epitope mapping in haemophilia A patients
    Moret, A.
    Haya, S.
    Quintana, M.
    Jimenez-Yuste, V
    Altisent, C.
    Parra, R.
    Perez, R.
    Lopez, M. F.
    Gimenez, F.
    Malcorra, J. J.
    Paloma, M. J.
    Prieto, M.
    Sedano, C.
    Soto, I
    Gutierrez, M. J.
    Cortina, V
    Galmes, B.
    Canaro, M.
    Aznar, J. A.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 519 - 520
  • [24] Real experience of prophylaxis with emicizumab in patients with congenital haemophilia A with and without FVIII inhibitors in the HCUVA
    Heredia Cano, Angela
    Garcia Candel, Faustino
    Sanchez Villalobos, Maria
    Poveda Garcia, Andrea
    Torchia Esteban, Marcos
    Ruiz Ruiz, Estela
    Sanchez Salas, Jose Antonio
    Navarro Almenzar, Begona
    Caracena Lopez, Sara
    Perez Laencina, Marta
    Blazquez Soto, Juan Antonio
    HAEMOPHILIA, 2024, 30 : 31 - 32
  • [25] Low inhibitor incidence in previously untreated haemophilia A patients treated with octanate
    Klukowska, A.
    Laguna, P.
    Jansen, M.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 373 - 373
  • [26] The prevalence and risk factors of inhibitor development of FVIII in previously treated patients with hemophilia A
    Kim, Ju Young
    You, Chur Woo
    BLOOD RESEARCH, 2019, 54 (03) : 204 - 209
  • [27] Inhibitors in patients with haemophilia A
    Kreuz, Wolfhart
    Ettingshausen, Carmen Escuriola
    THROMBOSIS RESEARCH, 2014, 134 : S22 - S26
  • [28] Inhibitor Development in Previously Untreated Patients with Severe Haemophilia a Treated with Human-CL RHFVIII, a New Generation Recombinant FVIII of Human Origin
    Neufeld, E. J.
    Abashidze, M.
    Aleinikova, O.
    Altisent, C.
    Belletrutti, M. J.
    Borel-Derlon, A.
    Carcao, M.
    Chambost, H.
    Chan, A. K. C.
    Dubey, L.
    Ducore, J.
    Fouzia, N. A.
    Gattens, M.
    Gruel, Y.
    Kavardakova, N.
    El Khorassani, M.
    Klukowska, A.
    Koenigs, C.
    Lambert, T.
    Liesner, R. J.
    Lohade, S.
    Sigaud, M.
    Turea, V.
    Wu, J. K.
    Vdovin, V.
    HAEMOPHILIA, 2017, 23 : 24 - +
  • [29] Factor VIII inhibitors in previously treated hemophilic patients
    Mannucci, P. M.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 (11) : 2328 - 2329
  • [30] Experience of Advate rAHF-PFM in previously untreated patients and minimally treated patients with haemophilia A
    Auerswald, Guenter
    Thompson, Alexis A.
    Recht, Michael
    Brown, Deborah
    Liesner, Raina
    Guzman-Becerra, Norma
    Dyck-Jones, Jacqueline
    Ewenstein, Bruce
    Abbuehl, Brigitt
    THROMBOSIS AND HAEMOSTASIS, 2012, 107 (06) : 1072 - 1082
12345